Focus on Valvular Heart Disease
December 2025
Table of contents
Valvular heart disease (VHD) remains a major contributor to patient morbidity and mortality. VHD also represents one of the most dynamic fields in cardiovascular medicine.
Advances in diagnostic techniques and algorithms for VHD assessment are evolving, oftentimes requiring multimodality approaches.
Indications and choice of intervention for patients suffering from VHD should be assessed within a multidisciplinary Heart Team in specialised heart valve centres, using a patient-centered approach.
This month, ESC FOCUS brings practical resources to help you understand and implement the 2025 ESC / EACTS Guidelines for the management of valvular heart disease. Essential for clinical practice, these guidelines provide a pragmatic, clinician-friendly roadmap for the diagnosis and treatment of VHD patients.
Webinars
Webinar
2025 ESC Guidelines on Valvular heart disease: what’s new in aortic stenosis
10 Dec 2025 - 19:00
Webinar
2025 ESC Guidelines on Valvular heart disease: what's new in mitral regurgitation?
17 Dec 2025 - 19:00
Essentials
ESC Guidelines resources
2025 ESC/EACTS Guidelines for the management of valvular heart disease - Full text
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease: Ask the Task Force
2025 ESC Guidelines and Document overview
Guidelines in Practice: 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Key supporting evidence
Dig deeper
Exclusively for members
In practice
Webinar
Tricuspid valve regurgitation management: what is new?
27 Jun 2022 - 20:00
Webinar
Aortic stenosis treatment options - which therapy for which patient?
21 Dec 2021 - 19:00
Webinar
The challenge of multiple and mixed valvular heart disease
12 Sep 2023 - 20:00
Webinar
Contemporary management of valvular heart disease
3 Apr 2023 - 20:00
Webinar
Contemporary management of mitral regurgitation in patients with heart failure
13 Jun 2024 - 20:00
Webinar
How would you manage severe valvular lesions (aortic and tricuspid) in heart failure patients?
26 Jun 2024 - 20:00
Webinar
Optimising TAVI outcomes: the ideal valvular heart team structure and role of the valve coordinator
4 Feb 2025 - 19:00
Congress Presentation
Case 1: multimodality imaging to guide management in a patient with mitral valve regurgitation
30 Aug 2025 - 13:00
Congress Presentation
Case 2: multimodality imaging to guide management in a patient with tricuspid valve regurgitation
30 Aug 2025 - 13:20
Congress Presentation
Case 1: patient with secondary mitral regurgitation and cardiogenic shock
31 Aug 2025 - 18:15
Congress Presentation
Case 2: simultaneous diagnosis of dilated cardiomyopathy and secondary mitral regurgitation
31 Aug 2025 - 18:35
Congress Presentation
Clinical Case Management: patients with secondary mitral regurgitation - discussion
31 Aug 2025 - 18:55
Congress Presentation
Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies - panel discussion 1
30 Aug 2024 - 10:47
Congress Presentation
Prognostic implications of paradoxical low gradient severe aortic stenosis: a comprehensive analysis from a large multicentric registry
29 Aug 2022 - 11:06
Congress Presentation
Interventional management of tricuspid regurgitation: the new frontier – discussion.
27 Aug 2022 - 14:00
Congress Presentation
Making a choice for the long road: surgical vs. transcatheter aortic valve replacement: lifetime management consequences – discussion.
26 Aug 2022 - 19:15
Congress Presentation
Quantification of valvular heart disease severity: challenges and solutions – discussion.
29 Aug 2022 - 19:15
Congress Session
Case conundrum: personalised imaging in asymptomatic severe regurgitant valve disease
31 Aug 2024 - 19:30
Congress Session
A critical evaluation of high-risk implantable devices in cardiology: insights from CORE-MD
28 Aug 2023 - 14:45
Congress Session
Guidelines in Practice: a patient with severe mitral regurgitation and coronary disease
27 Aug 2022 - 10:30
Interface with the specialists
European Heart Journal
Enhanced education to improve aortic stenosis patient pathways: the AortiCare programme
15 Oct 2025 - 02:00
Webinar
New vision of the tricuspid valve
15 Dec 2022 - 19:00
Webinar
Three-dimensional transoesophageal echocardiography: how to use and when to use in valvular heart disease
3 Feb 2023 - 19:00
Webinar
Tricuspid regurgitation and its new challenges
5 Mar 2024 - 19:00
Congress Presentation
The floor is yours: bring your questions on the current management of severe tricuspid regurgitation - expert panel
29 Aug 2025 - 13:05
Congress Presentation
The floor is yours: bring your questions on the current management of severe tricuspid regurgitation - get ready for the session
29 Aug 2025 - 13:00
Pioneers' Viewpoint
Webinar
Mitral and tricuspid regurgitations: tea for two
10 Jun 2025 - 20:00
Congress Presentation
Management of valvular heart disease in 2033.
28 Aug 2022 - 11:00
Congress Session
Great Debate: all patients with asymptomatic severe aortic stenosis need treatment
26 Aug 2022 - 10:30
Congress Session
Managing patients with multivalvular disease: expert insights
29 Aug 2022 - 10:30
Test yourself - eLearning courses
e-Learning Course
3D Echocardiography Tutorials - Focus on Valvular Heart Disease
9 Dec 2024 - 08:00
e-Learning Course
AortiCare-Improving the diagnosis referral and management of patients with AS
7 May 2025 - 08:00
e-Learning Course
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
12 Sep 2025 - 08:00
This programme is supported by Edwards Lifesciences through an independent support grant.
The scientific programme has not been influenced in any way by its grant provider.
ESC Pocket Guidelines Mobile App
Convenient resources available directly on your mobile device.
